Dapagliflozin versus empagliflozin in patients with chronic kidney disease.
Alnsasra H, Tsaban G, Solomon A, Khalil F, Aboalhasan E, Azab AN, Azuri J, Hammerman A, Arbel R.
Alnsasra H, et al. Among authors: azab an.
Front Pharmacol. 2023 Aug 4;14:1227199. doi: 10.3389/fphar.2023.1227199. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37601066
Free PMC article.